Form 4: Novavax Director James F. Young Sells Shares in Recent Transactions
SEC Form 4
Director James F. Young of Novavax Inc. (NVAX) recently sold a portion of his holdings in two separate transactions on June 18, 2024.
Summary
- On June 18, 2024, James F. Young, a director of Novavax Inc. (NVAX), sold 6,393 shares of common stock at a price of $13.62 per share.
- Following this transaction, Young sold an additional 1,107 shares at $14.28 per share on the same day.
- After these transactions, Young directly owns 69,260 shares of Novavax common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports stock sales by a company director, without indicating any positive or negative outlook for the company.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into a company's prospects, although they don't always indicate a definitive trend.
Stakeholder Impact
- Shareholders may react to the news of insider selling, potentially impacting the stock price.
Key Dates
| Date | Description |
|---|---|
| 06/18/2024 | Date of stock sale transactions |
| 06/21/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.